Equities

CK Life Sciences Intl (Holdings) Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

CK Life Sciences Intl (Holdings) Inc

Actions
  • Price (EUR)0.087
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+50.00%
  • Beta0.4764
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company is mainly engaged in human health businesses such as research and development, production, promotion and sales of health products and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.

  • Revenue in HKD (TTM)5.49bn
  • Net income in HKD-278.39m
  • Incorporated--
  • Employees1.94k
  • Location
    CK Life Sciences Intl (Holdings) Inc2 Dai Fu StreetTai Po Industrial Estate Hong KongHKG
  • Phone+852 21261212
  • Fax+852 21261211
  • Websitehttps://www.ck-lifesciences.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.